1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1067/mem.2000.110823" target="_blank" rel="noreferrer noopener">http://doi.org/10.1067/mem.2000.110823</a>
Pages
427–431
Issue
5
Volume
36
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
The bronchodilator effect of intravenous glucagon in asthma exacerbation: a randomized, controlled trial.
Publisher
An entity responsible for making the resource available
Annals of emergency medicine
Date
A point or period of time associated with an event in the lifecycle of the resource
2000
2000-11
Subject
The topic of the resource
Adult; Asthma/complications/*drug therapy; Bronchodilator Agents/*administration & dosage; Double-Blind Method; Female; Glucagon/*administration & dosage; Humans; Injections; Intravenous; Male
Creator
An entity primarily responsible for making the resource
Wilber S T; Wilson J E; Blanda M; Gerson L W; Meerbaum S O; Janas G
Description
An account of the resource
STUDY OBJECTIVE: Glucagon is a rapid-acting smooth muscle relaxant with a short half-life. Previous studies suggested glucagon may have bronchodilator effects. We sought to determine whether intravenous glucagon produces clinically important immediate bronchodilation in emergency department patients with asthma exacerbation. METHODS: We conducted a randomized, double-blind, placebo-controlled study at 2 university-affiliated community teaching hospital EDs (annual census 90,000). ED patients 18 to 50 years old with asthma exacerbation and peak expiratory flow rate (PEFR) less than 350 L/min were eligible. Exclusion criteria were need for intubation, chronic obstructive pulmonary disease, diabetes mellitus, insulinoma, pheochromocytoma, pregnancy, lactation, or current oral steroid treatment. Patients were randomly assigned to receive glucagon 0.03 mg/kg or an equivalent volume of saline solution intravenously. At 10 minutes, PEFR was measured and all patients began standardized albuterol therapy. Successful bronchodilation was a PEFR increase of 60 L/min at 10 minutes. RESULTS: Success occurred in 2 (9.5%) of 21 glucagon-treated patients and 3 (12%) of 25 placebo-treated patients (95% confidence interval [CI] for difference of -2.5% [-20.4% to 15. 4%]). Mean PEFR improvement for glucagon was 2 L/min versus 9 L/min for placebo (95% CI for difference of -7 L/min [-36 L/min to 23 L/min]). CONCLUSION: Glucagon alone provided no clinically important immediate bronchodilation in ED patients with asthma exacerbation.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1067/mem.2000.110823" target="_blank" rel="noreferrer noopener">10.1067/mem.2000.110823</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2000
Adult
Annals of emergency medicine
Asthma/complications/*drug therapy
Blanda M
Bronchodilator Agents/*administration & dosage
Department of Emergency Medicine
Double-Blind Method
Female
Gerson L W
Glucagon/*administration & dosage
Humans
Injections
Intravenous
Janas G
Male
Meerbaum S O
NEOMED College of Medicine
Wilber S T
Wilson J E